Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, a practice that has ...
Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was ...
Pharmacy closures are accelerating, leaving 45 million Americans in pharmacy deserts. Here's how to fix the problem.
China rivalry heats up, Chinese drugmakers are striking major deals with their global counterparts — including some in the ...
A trade group representing generic drugmakers is seeking an injunction to thwart a provision of a new Connecticut law that ...
Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...
In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT columnist Jason Karlawish.
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...
Since interagency cooperation isn’t succeeding organically, it’s time for top-down initiatives led by a Health and Human ...
Researchers worry that Medicaid home care eligibility decisions are often made without public scrutiny and based less on ...
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback